Insider · CIK 0002042496
Jay Lawrence Goodman
Files at FRMM (180 Life Sciences Corp.). First filing -, latest -.
In brief
Jay Lawrence Goodman files SEC Form 4 as director at FRMM (180 Life Sciences Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jay Lawrence Goodman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | FRMM 180 Life Sciences Corp. | AGrant or award Common Stock | +65,000 | $0.00 | $0 | 65,000 | Feb 21, 2025 |
Questions about Jay Lawrence Goodman
Answered from the filings on this page, as of the latest one.
Is Jay Lawrence Goodman buying or selling?
Jay Lawrence Goodman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jay Lawrence Goodman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jay Lawrence Goodman has 0.
Where does Jay Lawrence Goodman file Form 4?
Jay Lawrence Goodman has filed Form 4 at FRMM (180 Life Sciences Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.